Rapid Novor Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 56

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $5M

  • Investors
  • 4

Rapid Novor General Information

Description

Developer of protein sequencing technology designed to develop antibody proteins for pharmaceutical companies. The company's technology produces new antibodies directly from the sample with sequence accuracy and has the same binding affinity and also mass uses spectrometry to restore hybridoma cell line, confirm antibody products, examine post-translational modifications and glycosylations and accelerate biosimilar development, enabling medical researchers to develop and advance life science for better human health with next-generation protein sequencing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Unit 450
  • 137 Glasgow Street
  • Kitchener, Ontario N2G 4X8
  • Canada
+1 (855)
Primary Industry
Drug Discovery
Other Industries
Laboratory Services (Healthcare)
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Unit 450
  • 137 Glasgow Street
  • Kitchener, Ontario N2G 4X8
  • Canada
+1 (855)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rapid Novor Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 28-Jul-2020 $5M Completed Generating Revenue
3. Accelerator/Incubator 12-Feb-2018 Completed Generating Revenue
2. Accelerator/Incubator 20-Jul-2017 Completed Generating Revenue
1. University Spin-Out 28-Apr-2015 Completed Startup
To view Rapid Novor’s complete valuation and funding history, request access »

Rapid Novor Patents

Rapid Novor Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4754534-A1 Methods for the assembly of protein sequences in complex protein mixtures Pending 02-Aug-2023
WO-2025024921-A1 Methods for the assembly of protein sequences in complex proteins mixtures Inactive 02-Aug-2023
CA-3235238-A1 Method for detection and quantification of immunoglobulin free light chain dimers Active 08-Jul-2022
EP-4551946-A1 Method for detection and quantification of immunoglobulin free light chain dimers Pending 08-Jul-2022
EP-4551946-A4 Method for detection and quantification of immunoglobulin free light chain dimers Pending 08-Jul-2022 G01N33/6848
To view Rapid Novor’s complete patent history, request access »

Rapid Novor Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rapid Novor Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
China Growth Capital Venture Capital Minority
Co-Win Ventures Venture Capital Minority
Johnson & Johnson Innovation - JLABS Accelerator/Incubator
University of Waterloo University
To view Rapid Novor’s complete investors history, request access »

Rapid Novor FAQs

  • When was Rapid Novor founded?

    Rapid Novor was founded in 2015.

  • Where is Rapid Novor headquartered?

    Rapid Novor is headquartered in Kitchener, Canada.

  • What is the size of Rapid Novor?

    Rapid Novor has 56 total employees.

  • What industry is Rapid Novor in?

    Rapid Novor’s primary industry is Drug Discovery.

  • Is Rapid Novor a private or public company?

    Rapid Novor is a Private company.

  • What is Rapid Novor’s current revenue?

    The current revenue for Rapid Novor is .

  • How much funding has Rapid Novor raised over time?

    Rapid Novor has raised $5M.

  • Who are Rapid Novor’s investors?

    China Growth Capital, Co-Win Ventures, Johnson & Johnson Innovation - JLABS, and University of Waterloo have invested in Rapid Novor.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process